We use cookies to improve your experience

We value your privacy and strive to enhance your experience. By continuing to browse our site, you agree to our use of cookies to offer you tailored content and seamless services. Learn more

Biopharmaceutical Third Party Logistics Market Size, Share, and Trends 2024 to 2034

The global biopharmaceutical third party logistics market size is calculated at USD 152.89 billion in 2025 and is forecasted to reach around USD 271.76 billion by 2034, accelerating at a CAGR of 6.60% from 2025 to 2034. The North America market size surpassed USD 61.00 billion in 2024 and is expanding at a CAGR of 6.62% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : October 2023
  • Report Code : 1540
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID-19 Impact on Biopharmaceutical Third Party Logistics Market 

5.1. COVID-19 Landscape: Biopharmaceutical Third Party Logistics Industry Impact

5.2. COVID-19 - Impact Assessment for the Industry

5.3. COVID-19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Biopharmaceutical Third Party Logistics Market, By Service

8.1. Biopharmaceutical Third Party Logistics Market, by Service Type

8.1.1. Warehousing & Storage

8.1.1.1. Market Revenue and Forecast 

8.1.2. Transportation

8.1.2.1. Market Revenue and Forecast 

8.1.3. Others

8.1.3.1. Market Revenue and Forecast 

Chapter 9. Global Biopharmaceutical Third Party Logistics Market, By Supply Chain

9.1. Biopharmaceutical Third Party Logistics Market, by Supply Chain

9.1.1. Cold Chain

9.1.1.1. Market Revenue and Forecast 

9.1.2. Non-Cold Chain

9.1.2.1. Market Revenue and Forecast 

Chapter 10. Global Biopharmaceutical Third Party Logistics Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Forecast, by Service 

10.1.2. Market Revenue and Forecast, by Supply Chain 

10.1.3. U.S.

10.1.3.1. Market Revenue and Forecast, by Service 

10.1.3.2. Market Revenue and Forecast, by Supply Chain 

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Forecast, by Service 

10.1.4.2. Market Revenue and Forecast, by Supply Chain 

10.2. Europe

10.2.1. Market Revenue and Forecast, by Service 

10.2.2. Market Revenue and Forecast, by Supply Chain 

10.2.3. UK

10.2.3.1. Market Revenue and Forecast, by Service 

10.2.3.2. Market Revenue and Forecast, by Supply Chain 

10.2.4. Germany

10.2.4.1. Market Revenue and Forecast, by Service 

10.2.4.2. Market Revenue and Forecast, by Supply Chain 

10.2.5. France

10.2.5.1. Market Revenue and Forecast, by Service 

10.2.5.2. Market Revenue and Forecast, by Supply Chain 

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Forecast, by Service 

10.2.6.2. Market Revenue and Forecast, by Supply Chain 

10.3. APAC

10.3.1. Market Revenue and Forecast, by Service 

10.3.2. Market Revenue and Forecast, by Supply Chain 

10.3.3. India

10.3.3.1. Market Revenue and Forecast, by Service 

10.3.3.2. Market Revenue and Forecast, by Supply Chain 

10.3.4. China

10.3.4.1. Market Revenue and Forecast, by Service 

10.3.4.2. Market Revenue and Forecast, by Supply Chain 

10.3.5. Japan

10.3.5.1. Market Revenue and Forecast, by Service 

10.3.5.2. Market Revenue and Forecast, by Supply Chain 

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Forecast, by Service 

10.3.6.2. Market Revenue and Forecast, by Supply Chain 

10.4. MEA

10.4.1. Market Revenue and Forecast, by Service 

10.4.2. Market Revenue and Forecast, by Supply Chain 

10.4.3. GCC

10.4.3.1. Market Revenue and Forecast, by Service 

10.4.3.2. Market Revenue and Forecast, by Supply Chain 

10.4.4. North Africa

10.4.4.1. Market Revenue and Forecast, by Service 

10.4.4.2. Market Revenue and Forecast, by Supply Chain 

10.4.5. South Africa

10.4.5.1. Market Revenue and Forecast, by Service 

10.4.5.2. Market Revenue and Forecast, by Supply Chain 

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Forecast, by Service 

10.4.6.2. Market Revenue and Forecast, by Supply Chain 

10.5. Latin America

10.5.1. Market Revenue and Forecast, by Service 

10.5.2. Market Revenue and Forecast, by Supply Chain 

10.5.3. Brazil

10.5.3.1. Market Revenue and Forecast, by Service 

10.5.3.2. Market Revenue and Forecast, by Supply Chain 

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Forecast, by Service 

10.5.4.2. Market Revenue and Forecast, by Supply Chain 

Chapter 11. Company Profiles

11.1. Agility Logistics

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. AmerisourceBergen Corporation

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. DB Schenker

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. DHL International GmbH

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. FedEx Corporation

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Kerry Logistics Network Limited

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Kuehne + Nagel International AG

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. McKesson Corporation

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. SF Express Co. Ltd.

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. United Parcel Service of America, Inc.

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

According to Precedence Research, the global biopharmaceutical third party logistics market size was reached at USD 143.42 billion in 2024 and is anticipated to surpass over USD 271.76 billion by 2034.

The global biopharmaceutical third party logistics market is expected to drive growth at a CAGR of 6.60% from 2025 to 2034.

The burgeoning demand for the biopharmaceutical drugs across the developed and developing nations is a prominent factor that boosts the growth of the global biopharmaceutical third party logistics market.

The major players operating in the biopharmaceutical third party logistics market are Agility Logistics, AmerisourceBergen Corporation, DB Schenker, DHL International GmbH, FedEx Corporation, Kerry Logistics Network Limited, Kuehne + Nagel International AG, McKesson Corporation, SF Express Co. Ltd., United Parcel Service of America, Inc.

The North America region will lead the global biopharmaceutical third party logistics market in the forecast period.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client